Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.53B |
| 2 |
NVIDIA
NVDA
|
+$1.07B |
| 3 |
Capital One
COF
|
+$1.02B |
| 4 |
Apple
AAPL
|
+$998M |
| 5 |
Amazon
AMZN
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.09B |
| 2 |
Palantir
PLTR
|
+$671M |
| 3 |
Coca-Cola
KO
|
+$501M |
| 4 |
Qualcomm
QCOM
|
+$435M |
| 5 |
Applovin
APP
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.45% |
| 2 | Financials | 14.05% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.36% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Artelo Biosciences
ARTL
$2.55M
| $213K | ﹤0.01% |
5,344
+3,857
| +259% | +$71.3K |
|
3852
Century Therapeutics
IPSC
$353M
| $213K | ﹤0.01% |
380,277
-589,983
| -61% | -$317K |
|
|
KAZR
3853
Skyline Builders Group
KAZR
$55M
| $213K | ﹤0.01% |
16,855
+69
| +0.4% | +$807 |
|
3854
Ovid Therapeutics
OVID
$489M
| $212K | ﹤0.01% |
643,335
-687,658
| -52% | -$207K |
|
3855
Biodesix
BDSX
$256M
| $212K | ﹤0.01% |
37,544
-4,517
| -11% | -$36.5K |
|
|
FLNT
3856
Fluent
FLNT
$129M
| $211K | ﹤0.01% |
105,324
-460
| -0.4% | -$975 |
|
3857
Flux Power
FLUX
$12.5M
| $210K | ﹤0.01% |
139,065
-1,912
| -1% | -$3.11K |
|
|
DRRX
3858
DELISTED
DURECT Corp
DRRX
| $210K | ﹤0.01% |
330,268
-3,060
| -0.9% | -$1.97K |
|
3859
Sidus Space
SIDU
$253M
| $209K | ﹤0.01% |
120,799
+26,498
| +28% | +$40.2K |
|
3860
Endava
DAVA
$162M
| $205K | ﹤0.01% |
+13,356
| New | +$225K |
|
3861
Willamette Valley Vineyards
WVVI
$11.5M
| $204K | ﹤0.01% |
37,029
+119
| +0.3% | +$695 |
|
3862
AMCON Distributing
DIT
| $204K | ﹤0.01% |
2,664
+12
| +0.5% | +$899 |
|
3863
Trinity Capital Inc.
TRIN
$1.73B
| $203K | ﹤0.01% |
14,443
| – | – |
|
|
OKUR
3864
OnKure Therapeutics
OKUR
$159M
| $203K | ﹤0.01% |
84,895
-1,416
| -2% | -$3.71K |
|
|
STRM
3865
DELISTED
Streamline Health Solutions
STRM
| $203K | ﹤0.01% |
39,185
+1,951
| +5% | +$6.73K |
|
|
CNCK
3866
Coincheck Group
CNCK
$380M
| $202K | ﹤0.01% |
36,986
+15,983
| +76% | +$96K |
|
3867
Ark Restaurants
ARKR
$20.2M
| $201K | ﹤0.01% |
22,076
+189
| +0.9% | +$1.89K |
|
3868
Tenax Therapeutics
TENX
$64.4M
| $200K | ﹤0.01% |
34,236
+895
| +3% | +$5.17K |
|
3869
Sundial Growers
SNDL
$313M
| $200K | ﹤0.01% |
164,900
+673
| +0.4% | +$896 |
|
|
MESO
3870
Mesoblast
MESO
$2.18B
| $200K | ﹤0.01% |
18,320
+75
| +0.4% | +$840 |
|
|
QVCGA
3871
DELISTED
QVC Group Inc Series A
QVCGA
| $199K | ﹤0.01% |
72,421
-10,165
| -12% | -$58.5K |
|
3872
StealthGas
GASS
$331M
| $199K | ﹤0.01% |
31,075
+127
| +0.4% | +$728 |
|
3873
Armata Pharmaceuticals
ARMP
$158M
| $199K | ﹤0.01% |
104,546
-1,291
| -1% | -$2.09K |
|
3874
Curis
CRIS
$3.49M
| $198K | ﹤0.01% |
4,265
-52
| -1% | -$2.04K |
|
|
ELEV
3875
DELISTED
Elevation Oncology
ELEV
| $198K | ﹤0.01% |
538,656
-647,663
| -55% | -$216K |
|
Similar funds
Geode Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Geode Capital Management held 4,594 positions worth $1.43T, up 12% from $1.27T the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Geode Capital Management's Q2 2025 filing shows 119 new, 2,787 increased, 1,425 reduced and 150 closed positions. Its largest new stake was Emera Inc: 3,219,448 shares worth $152M. The largest sale was Discover Financial Services, an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q2 2025 buy was Emera Inc: 3,219,448 shares worth $152M.
- Geode Capital Management added most to Microsoft in Q2 2025, an estimated $1.53B increase.
- Geode Capital Management's biggest Q2 2025 reduction was Palantir, cutting an estimated $671M.
- Geode Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $1.09B.
- Geode Capital Management's ten largest holdings make up 32% of its $1.43T portfolio in Q2 2025.
- Geode Capital Management opened 119 new positions and closed 150 in Q2 2025.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $1.43T.
Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.